username: password:     Join free | Forgot password
Add to favorites    中文
home > news and events
Asia鈥檚 Most Substantial Clinical Outsourcing Congress. Shanghai, China February 2014

Clicks:326 Date:12/03/13
The growth of clinical activities in Asia and Asia Pacific is so significant that industry leaders believe that the Asia market will overtake the US by 2020. With the increasing interest these recent years, the congress will explore into discussing issues such as global and local clinical development strategies in oncology and other therapeutic areas in order to maximize the success from CRO selection.
 
Attend our 3rd Annual Clinical Trials & Outsourcing Asia Congress to explore into the invaluable insights of novel clinical development, clinical outsourcing strategies, biomarker clinical research and clinical trial management. Join us at InterContinental Hotel Shanghai, Pudong on 27th & 28th February 2014, this insightful event will attract over 150 senior level decision markers representing leading biotech companies, global pharma organisations and internationally renowned academic institutions.
 
New focus
Pharmaceutical companies have put substantial efforts into research to discover biomarkers yet there is still a long way to go to translate this into clinical practice. The next step in the process for pharmaceuticals is to qualify and validate the application of biomarkers before they can be safely used in clinical practice. Therefore, with the new Biomarkers stream addition to the 3rd Annual Clinical Trials & Outsourcing Asia Congress, this event is not to be missed.
 
To build on the clinical case studies shared at last year鈥檚 event, we are pleased to introduce the co-located 鈥4th Annual Pharma R&D Asia Congress鈥 focusing on discussions on innovative strategies to overcome these R&D issues and help accelerate development pipelines.

Speakers of the 3rd Annual Clinical Trials & Outsourcing Asia Congress include:
        路     Jun Bao, Senior Vice President, Shenogen Pharma Group, China
        路     Matthias Boedding, Global Safety Leader, Global Pharmacovigilance 鈥 Risk Management, Global R&D Center Beijing, Bayer Healthcare, China
        路     Robert Chen, Vice President, Global Strategy & Partnering, Genor BioPharma, China

Taking place on 27th&28th February 2014 at InterContinental Hotel Shanghai, Pudong, contact Freda Shi at Oxford Global on f.shi@oxfordglobalasia.com or call +65 6570 2208 for the full agenda and prices for attendance.

 

Related News>> more
  • ISPE Singapore Conference & Exhibition 2014 & Healthcare Facilities Asia4/17/2014
  • 5th CSHA Symposium: Structural Biology - From Atoms to Cells4/14/2014
  • RephiLe successfully presented at analytica 20144/10/2014
  • Biotech China Show Preview4/9/2014
  • Biotech China to Showcase Industrial Parks4/9/2014
  • CSHA 2014:Liver Metabolism, Diseases and Cancer4/3/2014
  • An Interview with Pall's Global Vaccine Market Manager Annelies Onraedt3/28/2014
  • 2nd Annual Single Cell Genomics and Transcriptomics Asia Congress3/28/2014
  • 4th Annual Next Generation Sequencing Asia Congress3/28/2014
  • RephiLe products exhibited at the 29th Joint Annual Conference of Biomedical Science3/21/2014
  • advertisement

    Copyright(C) 2006-2014 bio-equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙